Notably, diminished MAN1A1 levels correlate with impaired cell–cell adhesion and unfavorable prognosis in breast carcinoma [34], whereas its upregulation portends adverse outcomes in hepatocellular and ovarian carcinomas [35, 36], underscoring context-specific functions. Here, MAN1A1 is linked to ovarian carcinoma.